Current location:entertainment >>
Multinational firms swear by Shanghai on support plan for foreign R&D centers
entertainment6People have gathered around
IntroductionA new plan to support the development of foreign research and development centers in Shanghai has le ...
A new plan to support the development of foreign research and development centers in Shanghai has led executives and experts to say the city continues to be an attractive destination for foreign companies.
They took cognizance of the city's continued efforts to attract investment and brighten its business environment. More multinational corporations will set up their R&D facilities in the city — and this will serve as a growth impetus for the city's high-quality development, they said.
The Shanghai municipal government introduced the new plan as part of the city's efforts to implement the central government's plans to introduce more foreign investment and promote innovation in China.
The plan, which took effect on March 15, seeks to encourage the establishment of more foreign R&D centers and upgrade the innovation capacity of existing ones. The local government will further optimize the clearance procedures for R&D materials, support legitimate cross-border flow of R&D data, step up financial support, better protect intellectual property rights, provide supportive talent policies and introduce more favorable fiscal and tax policies for foreign R&D centers.
Foreign R&D centers are encouraged to set up public nonprofits for fundamental scientific research funds in Shanghai. While biosafety risk assessments are still needed, the time limit for quarantine approval will be shortened for imported genetically modified animals and plants and biological materials introduced by foreign R&D centers for national or municipal research projects, with entry and follow-up supervision procedures optimized.
Meanwhile, an important data catalog in China (Shanghai) Pilot Free Trade Zone will be formulated. Export of data outside the catalog does not need security assessment, standard contracts for personal information export, or personal information protection certification.
Work permits or residence permits granted to high-end foreign talent working at foreign R&D centers will be valid for as long as five years, according to the new plan.
According to Luo Dajin, director of the Science and Technology Commission of Shanghai, foreign R&D centers are of much importance as Shanghai strives to become an international innovation hub.
MNCs are more than welcome to step up investment and set up open innovation platforms in Shanghai. They are also encouraged to work more closely with companies throughout the value chain, universities and other local institutes to conduct fundamental research and explore more application scenarios, he said.
Sun Lixing, a researcher at the Institute of World Economy of the Shanghai Academy of Social Sciences, said Shanghai's appeal to foreign investors and MNCs remains unchanged. The city has been optimizing the composition of foreign-invested companies while also improving their overall quality.
A collective signing ceremony on Feb 27 saw 17 foreign companies receiving certification for regional R&D centers from the local government. The certification specifies benchmarks for research content, R&D conditions and investment value over time. Certified companies will be entitled to government incentives and R&D support.
The R&D center of Panasonic Information Systems (Shanghai) Co Ltd, one of the 17 newly certified companies, focuses on upgrading the manufacturing execution system, exploring digital transformation methods and the development of artificial intelligence technologies. The latter will account for half of the company's R&D expenses this year, said its general manager Zhao Guodong.
"Thanks to Shanghai's high level of internationalization, foreign companies can seek development here on an equal footing with Chinese domestic companies. Therefore, Panasonic will increase its investment in new energy and elderly care sectors in China," said Zhao.
During his meeting with Shanghai's Party Secretary Chen Jining in late February, Pascal Soriot, CEO of biopharmaceutical MNC AstraZeneca, said the company's Asia-Pacific headquarters and global R&D center are in Shanghai because of the city's importance.
With firm confidence in the development outlook of Shanghai in particular and China in general, AstraZeneca will continue to increase its innovation-focused investment in the country, explore new businesses and deepen cooperation with local innovative drugmakers to help promote the high-quality development of Shanghai's medical industry, he said.
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Global Gathering news portal”。http://latvia.spaceforanything.com/article-01e799929.html
Related articles
Fresh heartache for cancer
entertainmentCancer-stricken King Charles will be feeling fresh heartache after a former IRA commander confessed ...
Read moreJon Wysocki dead at 53: Staind drummer passes away
entertainmentThe music world is in mourning this Sunday, with word that original Staind drummer Jon Wysocki passi ...
Read moreTarget to lower prices on basic goods in response to inflation
entertainmentTarget plans to cut prices on thousands of consumer basics this summer, from diapers to milk, as inf ...
Read more
Popular articles
- Kristin Cavallari, 37, ignores critics of her age
- Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
- Minnesota Uber and Lyft driver pay package beats deadline to win approval in Legislature
- Red Lobster seeks bankruptcy protection after closing some restaurants
- Student fatally shot, suspect detained at Georgia's Kennesaw State University
- Student fatally shot, suspect detained at Georgia's Kennesaw State University
Latest articles
Medics remove 150 MAGGOTS from a woman's mouth after dental procedure left her with rotting tissue
Ohio judge to rule Monday on whether the state’s abortion ban stands
Kevin Pillar gets 1,000th career hit in Angels' win at Texas
Independent UN experts urge Yemen’s Houthis to free detained Baha'i followers
Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
Kristin Cavallari, 37, ignores critics of her age
LINKS
- There's bird flu in US dairy cows. Raw milk drinkers aren't deterred
- EDEN CONFIDENTIAL: Sarah Ferguson is in the pink with traditional German wedding frock
- Fire sale! Ant McPartlin's ex
- It's a boy! Scottie Scheffler arrives at PGA Championship with a newborn at home
- Florida man sentenced to 3 years in prison for firebombing California Planned Parenthood clinic
- Chris Pratt divides fans as he publicly snubs ex
- Maradona heirs say his Golden Ball trophy was stolen and want to stop its auction
- Paul Mescal looks suave as he reunites with glamorous Normal People co
- Prince Harry and Meghan Markle hint there are more quasi
- Fire sale! Ant McPartlin's ex